VREX (STOCKS)
Varex Imaging Corporation Common Stock
$11.420000
+0.240000 (+2.15%)
Prev close: $11.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Sunny S. Sanyal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $478.08M
- Employees
- 2,300
- P/E (TTM)
- -6.85
- P/B (TTM)
- 1.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q1)
|
$0.19 | $0.14 | +0.0543 | +40.01% |
|
Sep 2025 (Q4)
|
$0.37 | $0.19 | +0.1838 | +98.71% |
|
Jun 2025 (Q3)
|
$0.18 | $0.04 | +0.1443 | +404.20% |
|
Mar 2025 (Q2)
|
$0.26 | $0.14 | +0.1165 | +81.18% |
Financial Statements
| Revenues | $854.40M |
| Benefits Costs and Expenses | $912.30M |
| Cost Of Revenue | $562.60M |
| Costs And Expenses | $912.30M |
| Gross Profit | $291.80M |
| Nonoperating Income/Loss | -$34.30M |
| Operating Expenses | $315.40M |
| Selling, General, and Administrative Expenses | $132.20M |
| Research and Development | $89.30M |
| Operating Income/Loss | -$23.60M |
| Income/Loss Before Equity Method Investments | -$54.10M |
| Income/Loss From Continuing Operations After Tax | -$67.40M |
| Income/Loss From Continuing Operations Before Tax | -$57.90M |
| Income/Loss From Equity Method Investments | -$3.80M |
| Income Tax Expense/Benefit | $9.50M |
| Net Income/Loss | -$67.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | $300.00K |
| Net Income/Loss Attributable To Parent | -$67.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$67.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.62 |
| Diluted Earnings Per Share | -$1.63 |
| Basic Average Shares | 124,800,000 |
| Diluted Average Shares | 135,100,000 |
| Assets | $1.10B |
| Current Assets | $633.60M |
| Inventory | $328.00M |
| Other Current Assets | $305.60M |
| Noncurrent Assets | $464.40M |
| Intangible Assets | $14.70M |
| Other Non-current Assets | $449.70M |
| Liabilities | $607.20M |
| Current Liabilities | $163.00M |
| Accounts Payable | $78.90M |
| Other Current Liabilities | $84.10M |
| Noncurrent Liabilities | $444.20M |
| Long-term Debt | $367.60M |
| Other Non-current Liabilities | $76.60M |
| Equity | $490.80M |
| Equity Attributable To Noncontrolling Interest | $13.90M |
| Equity Attributable To Parent | $476.90M |
| Liabilities And Equity | $1.10B |
| Net Cash Flow From Operating Activities | $16.10M |
| Net Cash Flow From Operating Activities, Continuing | $16.10M |
| Net Cash Flow From Investing Activities | $5.60M |
| Net Cash Flow From Investing Activities, Continuing | $5.60M |
| Net Cash Flow From Financing Activities | -$202.40M |
| Net Cash Flow From Financing Activities, Continuing | -$202.40M |
| Net Cash Flow | -$180.10M |
| Net Cash Flow, Continuing | -$180.70M |
| Comprehensive Income/Loss | -$72.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $300.00K |
| Comprehensive Income/Loss Attributable To Parent | -$72.90M |
| Other Comprehensive Income/Loss | -$5.20M |